Rehab facilities

Pharmacology of Rasagiline, a New MAO-B Inhibitor Drug for the Treatment of Parkinson’s Disease With Neuroprotective Potential.

Pharmacology of Rasagiline, a New MAO-B Inhibitor Drug for the Treatment of Parkinson’s Disease with Neuroprotective Potential.

Rambam Maimonides Med J. 2010 Jul; 1(1): e0003
Finberg JP

Rasagiline (Azilect) is a highly selective and potent propargylamine inhibitor of monoamine… Continue reading

Rehab Facilities in Las Vegas Rehab Centers in Las Vegas Rehab Facilities in Las Vegas

Rehab Facilities in Las Vegas Rehab Centers in Las Vegas Rehab Facilities in Las Vegas


 

 

Oldest SunPass transponders need to be replaced
The notifications sent to SunPass drivers will include detailed instructions on how to replace their transponders,… Continue reading

Evesham Designates Three Properties Ripe for Condemnation

Evesham designates three properties ripe for condemnation
The long-shuttered Olga's Diner, the former G-Boys Garden & Christmas Center and the Tri-Towne Plaza have all been officially designated in need of redevelopment, opening the door to condemnation. “Right now, they're not… Continue reading

From 32 Ounces to Zero: A Medical Geographic Study of Dispensing a Cultivated Batch of “plum” Cannabis Flowers to Medical Marijuana Patients in Washington State.

From 32 ounces to zero: a medical geographic study of dispensing a cultivated batch of “plum” cannabis flowers to medical marijuana patients in Washington State.

J Psychoactive Drugs. 2013 Apr-Jun; 45(2): 141-55
Aggarwal SK, Carter GT, Zumbrunnen C, Morrill… Continue reading

Predictors of Residential Treatment Retention Among Individuals With Co-Occurring Substance Abuse and Mental Health Disorders.

Predictors of residential treatment retention among individuals with co-occurring substance abuse and mental health disorders.

J Psychoactive Drugs. 2013 Apr-Jun; 45(2): 122-31
Choi S, Adams SM, MacMaster SA, Seiters J

A significant number of individuals with co-occurring substance abuse… Continue reading

Psychoeducation Improves Hepatitis C Virus Treatment During Opioid Substitution Therapy: A Controlled, Prospective Multicenter Trial.

Psychoeducation improves hepatitis C virus treatment during opioid substitution therapy: a controlled, prospective multicenter trial.

Clin Infect Dis. 2013 Aug; 57 Suppl 2: S97-S104
Reimer J, Schmidt CS, Schulte B, Gansefort D, Gölz J, Gerken G, Scherbaum N, Verthein… Continue reading

Association Between Ward-Specific Antimicrobial Use Density and Methicillin-Resistant Staphylococcu Aureus Surveillance: A 60-Month Study.

Association between ward-specific antimicrobial use density and methicillin-resistant Staphylococcu aureus surveillance: a 60-month study.

Infect Drug Resist. 2013; 6: 59-66
Yoshida J, Kikuchi T, Matsubara N, Asano I, Ogami N

It is not known whether or not ward-specific antimicrobial… Continue reading

Unintentional Weakness of Cancers: The MEK/ERK Pathway as a Double-Edged Sword.

Unintentional weakness of cancers: the MEK/ERK pathway as a double-edged sword.

Mol Cancer Res. 2013 Jul 30;
Suda K, Mitsudomi T

Recent advances in molecular target therapy have greatly improved treatment outcomes for cancers driven by oncogenic mutations. However… Continue reading

Subjective Assessment of Rehabilitation Protocol by Patients After ACL Reconstruction – Preliminary Report.

Subjective Assessment of Rehabilitation Protocol by Patients after ACL Reconstruction – Preliminary Report.

Ortop Traumatol Rehabil. 2013 Jun 28; 15(3): 215-25
Chrzan D, Kusz D, Bo?tu? W, Bry?a A, Kusz B

HubMed – rehab

Randomized Controlled Trial of a… Continue reading

A Study of 6-Year Retention in Methadone Maintenance Treatment Among Opioid-Dependent Patients in Xi’an.

A Study of 6-Year Retention in Methadone Maintenance Treatment Among Opioid-Dependent Patients in Xi’an.

J Addict Med. 2013 Jul 26;
Wei X, Wang L, Wang X, Li J, Li H, Jia W

We analyzed a 6-year methadone maintenance treatment (MMT) retention rate in 8 MMT clinics in Xi’an and the factors that influenced the retention rate.We conducted a 6-year retrospective dynamic cohort study of 5849 eligible patients from 2006 to 2011. Participants were serially enrolled on the basis of opioid addiction, age, residence status, and civil capacity. Cumulative retention in treatment was calculated using survival analyses (life tables) on the basis of the number of days in MMT. We also used the Cox proportional hazard regression model to analyze the factors that may influence treatment retention.The MMT retention varied from a less than 1 month to a maximum of 71.2 months; the average dose was 48.76 ± 17.03 mg/d. The cumulative retention for 12, 24, 36, 48, 60, and 72 months after MMT initiation were 0.87, 0.76, 0.66, 0.57, 0.49, and 0.43, respectively. The MMT retention rate was significantly associated with factors that included the particular clinic for MMT, the year when the subject initiated MMT, average daily dose, hidden drug use, sex, age, length of drug abuse history, needle sharing, living arrangements, and employment status.The 6-year retention rates for MMT in the 8 clinics in Xi’an were higher than those reported in other studies of other clinics. High therapeutic doses (>60 mg/d) could reduce the risk of… Continue reading